Jaume Mestre Torres

Institutions of which they are part

Main researcher
Systemic Diseases

Vall Hebron Institut de Recerca

Jaume Mestre Torres

Institutions of which they are part

Main researcher
Systemic Diseases

Vall Hebron Institut de Recerca

Related news

New method to improve diagnosis and classification of patients with scleroderma

The new technology allows more sensitive detection of scleroderma patients' autoantibodies, which are related to the severity and progression of the disease.

Vall d'Hebron discovers a new antibody for the diagnosis of patients with scleroderma

Researchers have used an innovative protocol to identify people with this autoimmune disease who have a higher risk of cancer.

SYNLAB and Vall d'Hebron sign collaboration agreement to promote medical research

It will allow the promotion of research on systemic autoimmune-based diseases that especially affect women of childbearing age and, therefore, can also appear during pregnancy.